Important announcement: Following the 2026 merger of Patient Advocate Foundation and the PAN Foundation, this website is now part of Patient Advocate Foundation and remains active during the transition. If you are currently receiving assistance, or would like to apply, visit TotalAssist.org to find your fund and access your account. For help by phone, call 866-512-3861, Monday through Friday, 8:30am to 5:30pm ET. Learn more about the merger and our organization.

PAN joins letter thanking Congress for including requested report language about Medicare Prescription Payment Plan

During our transition, where to find information about:

The PAN Foundation and more than 50 patient advocate and healthcare organizations submitted a letter to the House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies, thanking them for including their previously requested report language regarding the Medicare Prescription Payment Plan.

Congress enacted the MPPP to provide Medicare Part D beneficiaries the option to pay their prescription drug costs in monthly installments over the course of a plan year. This is particularly impactful for beneficiaries with high-cost medication on fixed incomes. Being a new program that a beneficiary must opt into, significant outreach and education efforts, including collaboration with providers and pharmacies, are necessary.

The success of MPPP will, in part, be dictated by the ability to reach these individuals and help them understand their new option to enroll and smooth their out-of-pocket payments over the course of the year.

The report language previously requested by these advocacy organizations asks the Centers for Medicare and Medicaid Services (CMS) to report to Congress on uptake of the MPPP, the methods by which CMS is educating beneficiaries about the program, identifying barriers to participation, and outreach efforts with stakeholders such as provider associations and societies, patient and consumer advocacy groups, pharmacy benefit managers, pharmacies, and health insurance providers. CMS is also instructed to continue to explore mechanisms to facilitate point-of-sale enrollment to ensure easy access to the program.

Read the letter to Congress